Phase II clinical trial of THN102

Trial Profile

Phase II clinical trial of THN102

Phase of Trial: Phase II

Latest Information Update: 17 Jan 2018

At a glance

  • Drugs Flecainide/modafinil (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2018 New trial record
    • 11 Jan 2018 According to a Theranexus media release, this trial is expected to start in 2018 and its results are expected in the second quarter of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top